As of recent reports, Dr. Schuth holds a substantial stake in Denali Therapeutics, Inc., the company he helped establish and grow. His shares have fluctuated as the company navigated various phases in the biotech industry. At one point, his holdings...

$17.14M25.16%

Nov 20, 2024

Stock Sold

$17.31M

DNLI

$17.31M

412,880 shares

What if they kept their stock?

If Alexander Schuth, M.D. didn't sell their stock, today they would have:
Extra DNLI412,880 shares worth $10.18M.
This is -41.19% and $7.13M less than what they got when they sold the stock.
If they kept all their stock, their total holdings would be worth $27.32M.

Recent Insider Trades

DNLI

$63.11K

DNLI at $24.78/share

Aug 20, 2024

Sale

DNLI

$137.40K

DNLI at $23.67/share

Aug 20, 2024

Sale

DNLI

$52.01K

DNLI at $22.89/share

Aug 13, 2024

Sale

DNLI

$355.46K

DNLI at $17.66/share

Feb 13, 2024

Sale

DNLI

$46.96K

DNLI at $17.29/share

Feb 13, 2024

Sale

DNLI

$193.76K

DNLI at $19.43/share

Jan 5, 2024

Sale

DNLI

53,720 shares

DNLI

Jan 3, 2024

Received

DNLI

$58.43K

DNLI at $23.17/share

Aug 23, 2023

Sale

DNLI

$55.98K

DNLI at $22.59/share

Aug 21, 2023

Sale

DNLI

$65.61K

DNLI at $23.67/share

Aug 14, 2023

Sale

Rivals

Competitors/colleagues of Alexander Schuth, M.D.

Alexander Schuth, M.D.

CEO of Denali Therapeutics Inc.

D

View Compensation History

2022 Total Compensation

$737.20K

Salary

$500.00K

Bonus

$225.00K

Stock

$0.00

Other

$12.20K